TrialLeukemia2026

ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

Andreas Hochhaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.